4 Fortune 500 Industry Leaders Boast Ideal April/May Dividends

May 02, 2024 5:59 AM ET, , , , , , , , , , , , , ,

Summary

  • The Summer 2023 edition of Fortune Magazine revealed the 500 biggest U.S. companies by revenue. Dogcatcher’s quest to sniff out the best dividend buys focused on 68 industry leaders.
  • Those 68 industry leaders were segmented into 21 business sectors, ranging (alphabetically) from apparel to wholesalers. 3 of the 68 were private or foreign-exchange listed firms, leaving 65 listed.
  • 58 dividend-yielding stocks led those 68 industry leaders and ranged from 0.14% to 8.07% in annual yield and ranged -from 0.89% to 36.96% in broker-estimated one-year target-price upsides.
  • The top ten F500-IL boasted net gains from 16.82% to 32.89% per April YCharts data.
  • $5k invested in the lowest priced five of ten top yield F500-IL showed 17.14% more net gain than from $5k invested in all ten. Little (lower-priced) stocks sustained their lead of this F500-IL pack by over one and two-thirds lengths into April/May.
  • Looking for a portfolio of ideas like this one? Members of The Dividend Dog Catcher get exclusive access to our subscriber-only portfolios. Learn More »

Win 500 points on a wheel of fortune

McKevin

Foreword

This article is based on Fortune magazine's 2023 survey of 500 Largest U.S. Corporations (F500-IL).

"Size matters: the 50 largest companies on this year's list accounted for 49% of total Fortune 500 revenue and 45% of earnings." This article covers those 50

Get The Whole Fortune 500 Industry Leaders 'Safer' Dividend Underdog Story

Click here to subscribe to The Dividend Dogcatcher & get more information.

Catch A Dog On Facebook the evening before every NYSE trade day on Facebook/Dividend Dog Catcher, A Fredrik Arnold live video highlights a portfolio candidate in the Underdog Daily Dividend Show!

Root for the Underdog. Comment below on your favorite or least favorite stock tickers to make them eligible for inclusion in my next FA reader report.

This article was written by

31.22K Followers

Fredrik Arnold is a retired quality service analyst sharing investment ideas with a primary focus on dividend yields by utilizing free cash flow and one-year total returns as trading indicators.

He is the leader of the investing group The Dividend Dog Catcher, where he shares a minimum of one new dividend stock idea per week with focus on yield or extraordinary financial circumstances. All ideas are archived and available after weekly announcement. Learn more.

Analyst’s Disclosure:I/we have a beneficial long position in the shares of PFE either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Disclaimer: This article is for informational and educational purposes only and should not be construed to constitute investment advice. Nothing contained herein shall constitute a solicitation, recommendation or endorsement to buy or sell any security. Prices and returns on equities in this article except as noted are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling same.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Related Stocks

SymbolLast Price% Chg
ET--
Energy Transfer LP Common Units
VZ--
Verizon Communications Inc.
PFE--
Pfizer Inc.
F--
Ford Motor Company
CVS--
CVS Health Corporation

Related Analysis